- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Astellas Pharma Europe BV
Total 144 results
-
Astellas Pharma Europe B.V.CompletedNeuropathic Pain | Post-Herpetic Neuralgia (PHN) | Painful Diabetic Peripheral Neuropathy (PDPN)Czechia, Germany, Poland, United Kingdom
-
Astellas Pharma Europe B.V.Terminated
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP6294United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy VolunteersUnited Kingdom, Germany
-
Astellas Pharma Europe B.V.TerminatedHealthy Subjects | Pharmacokinetics of ASP2205United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy | Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Phase 1Netherlands
-
Astellas Pharma Europe B.V.CompletedHealthy Volunteers | Pharmacokinetics of ASP7962United Kingdom
-
Astellas Pharma Europe Ltd.TerminatedValidation | Dried Blood Spot | Transplant PatientsFrance, United Kingdom
-
Astellas Pharma Europe B.V.TerminatedClostridium DifficileFrance, Germany, Netherlands, Spain
-
Astellas Pharma Europe Ltd.CompletedPeripheral Neuropathic PainAustria, Greece, Italy, Portugal, Spain, Switzerland, United Kingdom
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP8477 | Pharmacodynamics of ASP8477France, Belgium
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Drug-Drug Interaction (DDI)Germany
-
Astellas Pharma Europe B.V.CompletedTolerability | Safety | Pharmacokinetics of ASP7962United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | DDI (Drug-Drug Interaction)Germany
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905 | Multiple DoseUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy SubjectsUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP1707United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP3652 | Pharmacodynamics of ASP3652United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Mild and Moderate Hepatic ImpairmentSlovakia
-
Astellas Pharma Europe B.V.Completed
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Drug-Drug Interaction (DDI)United Kingdom
-
Astellas Pharma Europe Ltd.CompletedOveractive Bladder (OAB) | Lower Urinary Tract Symptoms (LUTS)Ireland
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Bioavailability of IpragliflozinUnited Kingdom
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedKidney Transplantation | Renal Transplantation | Transplantation, Kidney | Grafting, Kidney | Transplantation, RenalBelgium, Germany, Spain, Sweden, Italy, Switzerland, United Kingdom, Austria, France, Poland, Czech Republic, Netherlands
-
Astellas Pharma Europe Ltd.Active, not recruitingLiver Transplantation | Kidney Transplantation | Heart Transplantation | Lung Transplantation | Intestine TransplantationBelgium, Czechia, France, Germany, Italy, Poland, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedModerate to Severe Vasomotor SymptomsUnited Kingdom
-
Astellas Pharma Europe Ltd.CompletedVasomotor Symptoms | MenopauseUnited Kingdom
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor OveractivityBelgium, Denmark, Norway, Poland, Serbia
-
Astellas Pharma Europe B.V.CompletedHealthy VolunteersUnited States
-
Astellas Pharma Europe B.V.CompletedInterstitial Cystitis | Bladder Pain SyndromeSpain, Russian Federation, Belgium, Czechia, Germany, Hungary, Latvia, Netherlands, Poland, United Kingdom
-
Astellas Pharma Europe Ltd.Completed
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Type 2 Diabetes Mellitus (T2DM) | Chronic Kidney Disease (CKD) | Pharmacokinetics of ASP8232 | Pharmacodynamics of ASP8232Bulgaria, Moldova, Republic of, Romania
-
Astellas Pharma Europe B.V.CompletedDiabetes Mellitus | Diabetic Macular EdemaUnited States
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesBelgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
-
Astellas Pharma Europe B.V.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaBelgium, Italy, France, Austria, United Kingdom, Netherlands, Poland, Slovakia, Belarus, Germany, Czechia
-
Astellas Pharma Europe B.V.CompletedType 2 Diabetes MellitusGermany
-
Astellas Pharma Europe B.V.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaBelgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, Czech Republic, Germany, Spain, Sweden, United Kingdom
-
Astellas Pharma Europe B.V.CompletedAdvanced Prostate CarcinomaRussian Federation
-
Astellas Pharma Europe Ltd.CompletedHerpes Zoster | Herpes GenitalisFrance
-
Astellas Pharma Europe B.V.CompletedHealthy VolunteersUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedVenous Thromboembolism | Arthroplasty, Replacement, HipDenmark, Spain, United States, Austria, Colombia, Russian Federation, India, Italy, United Kingdom, Germany, Hungary, Estonia, Romania, South Africa, Israel, Poland, Sweden, Canada, Australia, Lithuania, Ukraine, Latvia, Finland, Brazil, Slovak... and more
-
Astellas Pharma Europe B.V.CompletedHealthy SubjectsUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP1707 | Pharmacodynamics of ASP1707France
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Urinary Incontinence | Urge IncontinenceFrance, Belgium, Spain, Turkey, Australia, Russian Federation, Hungary, Italy, Netherlands, Poland, Czech Republic
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Drug-Drug Interaction (DDI)France
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP3652United Kingdom
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation